Description
Developer of drug and medical devices. The company has developed p63 gene which is involved in the diagnosis of prostate cancer and many other cancers.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Peter McKeon | Managing Director & Board Member | ||
Frank McKeon Ph.D | Executive | ||
Matthew Vincent Ph.D | Executive |
Name | Representing | Role | Since |
---|---|---|---|
Peter McKeon | AsymmetRx Medical | Managing Director & Board Member | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Johns Hopkins Technology Ventures | Accelerator/Incubator | 000 0000 | 000000 0 |